<<

Factsheet March 2019

What is clocapramine?

Second generation (sometimes referred to as ‘atypical’ NeuRA (Neuroscience antipsychotics) such as clocapramine are a newer class of medication Research Australia) than first generation ‘typical’ antipsychotics. Second generation antipsychotics are is one of the largest independent medical effective for the positive symptoms of schizophrenia. It is sometimes claimed that and clinical research they are more effective than first generation antipsychotics in treating the negative institutes in Australia and symptoms of schizophrenia, although the evidence for this is weak. Negative an international leader in neurological research. symptoms include a lack of ordinary mental activities such as emotional expression, social engagement, thinking and motivation, whereas positive symptoms include the Diseases of the brain and experiences of perceptual abnormalities () and fixed, false, irrational nervous system pose the greatest health, economic beliefs (). Second generation antipsychotics may also cause less extra- and social burden of any pyramidal side effects. These include such as repetitive, involuntary, disease group because they and purposeless body or facial movements, Parkinsonism (cogwheel muscle rigidity, are chronic, debilitating and have no known cures. pill-rolling tremor and reduced or slowed movements), akathisia (motor restlessness, especially in the legs, and resembling agitation) and dystonias such as muscle Medical research is the cornerstone of efforts to contractions causing unusual twisting of parts of the body, most often in the neck. advance the health and These effects are caused by the action of these wellbeing of families and the drugs. community. Our dedicated scientists are focussed on transforming their research What is the evidence for clocapramine? into significant and practical benefits for all patients. Moderate quality evidence suggests no differences between clocapramine and While we hope you find first or second generation antipsychotics for discontinuation or response, although this information useful, in comparison with second generation antipsychotics only, clocapramine was it is always important to less effective. There is less incidence of headaches and decreased appetite with discuss any questions about schizophrenia or clocapramine. its treatment with your doctor or other health care provider. For more information see the technical table

We are able to make significant advances due to the generosity of countless people. Your donation allows us HOW YOUR to continue to work towards transforming lives. For information on how you can support our research, phone SUPPORT HELPS 1300 888 019 or make a secure donation at neura.edu.au/donate/schizophrenia.

NeuRA (Neuroscience Research Australia) Foundation Margarete Ainsworth Building T 1300 888 019 F +61 2 9399 1082 Barker Street, Randwick NSW 2031 ABN 57 008 429 961 PO Box 1165 Randwick Sydney NSW 2031 Australia neura.edu.au